HilleVax (NASDAQ:HLVX) Shares Gap Down to $21.02
HilleVax (NASDAQ:HLVX) Shares Gap Down to $21.02
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $21.02, but opened at $20.42. HilleVax shares last traded at $20.51, with a volume of 50 shares.
HilleVax Stock Up 0.1 %
The business's 50 day moving average is $19.37 and its two-hundred day moving average is $14.70. The company has a debt-to-equity ratio of 0.02, a quick ratio of 34.77 and a current ratio of 34.77.
Get HilleVax alerts:Hedge Funds Weigh In On HilleVax
Hedge funds have recently bought and sold shares of the company. Strs Ohio acquired a new stake in HilleVax in the second quarter worth $32,000. TD Asset Management Inc. acquired a new stake in HilleVax in the second quarter worth $203,000. Frazier Life Sciences Management L.P. acquired a new stake in HilleVax in the second quarter worth $101,493,000. JPMorgan Chase & Co. acquired a new stake in HilleVax in the second quarter worth $76,000. Finally, Alps Advisors Inc. acquired a new stake in HilleVax in the second quarter worth $217,000.
HilleVax Company Profile
(Get Rating)HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Read More
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick's Sporting Goods
- Want to Get a 10% Dividend Yield, Look Here
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $21.02, but opened at $20.42. HilleVax shares last traded at $20.51, with a volume of 50 shares.
週三股市開盤前,希爾瓦克斯公司股價下跌。該股此前收盤報21.02美元,開盤報20.42美元。HilleVax股價最新報20.51美元,成交量為50股。
HilleVax Stock Up 0.1 %
HilleVax股價上漲0.1%
The business's 50 day moving average is $19.37 and its two-hundred day moving average is $14.70. The company has a debt-to-equity ratio of 0.02, a quick ratio of 34.77 and a current ratio of 34.77.
該業務的50日移動均線切入位在19.37美元,200日移動均線切入位在14.70美元。該公司的負債權益比為0.02,速動比率為34.77,流動比率為34.77。
Hedge Funds Weigh In On HilleVax
對衝基金入股HilleVax
Hedge funds have recently bought and sold shares of the company. Strs Ohio acquired a new stake in HilleVax in the second quarter worth $32,000. TD Asset Management Inc. acquired a new stake in HilleVax in the second quarter worth $203,000. Frazier Life Sciences Management L.P. acquired a new stake in HilleVax in the second quarter worth $101,493,000. JPMorgan Chase & Co. acquired a new stake in HilleVax in the second quarter worth $76,000. Finally, Alps Advisors Inc. acquired a new stake in HilleVax in the second quarter worth $217,000.
對衝基金最近買賣了該公司的股票。今年第二季度,俄亥俄州STRS收購了HilleVax價值3.2萬美元的新股份。道明資產管理公司(TD Asset Management Inc.)在第二季度收購了價值20.3萬美元的HilleVax新股份。弗雷澤生命科學管理公司在第二季度收購了HilleVax價值101,493,000美元的新股份。摩根大通在第二季度收購了價值7.6萬美元的HilleVax新股份。最後,Alps Advisors Inc.在第二季度收購了價值21.7萬美元的HilleVax新股份。
HilleVax Company Profile
HilleVax公司簡介
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HilleVax,Inc.是一家臨牀階段的生物製藥公司,專注於開發和商業化新型疫苗。該公司正在開發HIL-214,這是一種基於病毒樣顆粒的候選疫苗,用於預防由諾沃克病毒感染引起的中到重度急性胃腸炎。該公司總部設在馬薩諸塞州波士頓。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick's Sporting Goods
- Want to Get a 10% Dividend Yield, Look Here
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- 免費獲取StockNews.com關於HilleVax的研究報告(HLVX)
- 在取消了13%的股息後,Lumen Technologies可以擁有嗎?
- 思科希望重組削減成本以增加收入
- Dick‘s體育用品的賣方上限收益
- 想要獲得10%的股息收益率,看看這裏
- 炒股:3只有吸引力的股票,交易價格在10美元左右
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.
接收HilleVax Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HilleVax和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧